Literature DB >> 10428695

The scientific challenge of hepatitis C.

J Cohen.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10428695     DOI: 10.1126/science.285.5424.26

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  62 in total

1.  No requirement of HCV 5'NCR for HCV-like particles assembly in insect cells.

Authors:  Wei Zhao; Guo-Yang Liao; Yan-Jun Jiang; Shu-De Jiang
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

2.  Seroprevalence of hepatitis B and C in subjects admitted to a cardiology clinics in Turkey.

Authors:  O Ozdemir; K Arda; M Soylu; O Alyan; A D Demir; E Kütük
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

3.  Investigation of residual hepatitis C virus in presumed recovered subjects.

Authors:  Kei Fujiwara; Robert D Allison; Richard Y Wang; Patricia Bare; Kentaro Matsuura; Cathy Schechterly; Krishna Murthy; Francesco M Marincola; Harvey J Alter
Journal:  Hepatology       Date:  2012-12-06       Impact factor: 17.425

4.  Survival of hepatitis C virus in syringes: implication for transmission among injection drug users.

Authors:  Elijah Paintsil; Huijie He; Christopher Peters; Brett D Lindenbach; Robert Heimer
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

5.  Quasispecies as predictive response factors for antiviral treatment in patients with chronic hepatitis C.

Authors:  Javier Salmerón; Paloma Muñoz De Rueda; Angela Ruiz-Extremera; Jorge Casado; Carlos Huertas; Maria Del Carmen Bernal; Luis Rodríguez; Angel Palacios
Journal:  Dig Dis Sci       Date:  2006-05       Impact factor: 3.199

6.  Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A.

Authors:  Yang Cheng; Sébastien Dharancy; Mathilde Malapel; Pierre Desreumaux
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

7.  Poor response to pegylated interferon and ribavirin in older women infected with hepatitis C virus of genotype 1b in high viral loads.

Authors:  Hitomi Sezaki; Fumitaka Suzuki; Yusuke Kawamura; Hiromi Yatsuji; Tetsuya Hosaka; Norio Akuta; Masahiro Kobayashi; Yoshiyuki Suzuki; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Yuzo Miyakawa; Hiromitsu Kumada
Journal:  Dig Dis Sci       Date:  2008-10-28       Impact factor: 3.199

8.  High-throughput binding analysis determines the binding specificity of ASF/SF2 on alternatively spliced human pre-mRNAs.

Authors:  Brian Chang; J Levin; William A Thompson; William G Fairbrother
Journal:  Comb Chem High Throughput Screen       Date:  2010-03       Impact factor: 1.339

9.  Characterization of the specific CD4+ T cell response against the F protein during chronic hepatitis C virus infection.

Authors:  De-Yong Gao; Gen-Di Jin; Bi-Lian Yao; Dong-Hua Zhang; Lei-Lei Gu; Zhi-Meng Lu; Qiming Gong; Yu-Chun Lone; Qiang Deng; Xin-Xin Zhang
Journal:  PLoS One       Date:  2010-12-06       Impact factor: 3.240

10.  Hepatitis C seroprevalence and associated risk factors, Anyang, China.

Authors:  Fangfang Liu; Ke Chen; Zhonghu He; Tao Ning; Yaqi Pan; Hong Cai; Yang Ke
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.